Peng Gong

4.4k total citations
68 papers, 1.2k citations indexed

About

Peng Gong is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Peng Gong has authored 68 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 27 papers in Molecular Biology and 18 papers in Epidemiology. Recurrent topics in Peng Gong's work include Pancreatic and Hepatic Oncology Research (14 papers), Neuroendocrine Tumor Research Advances (8 papers) and RNA modifications and cancer (7 papers). Peng Gong is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Neuroendocrine Tumor Research Advances (8 papers) and RNA modifications and cancer (7 papers). Peng Gong collaborates with scholars based in China, Germany and Singapore. Peng Gong's co-authors include Xianbin Zhang, Haidong Bao, Ke Jiang, Zhongyu Wang, Songshu Meng, Yuru Shang, Xin Dong, Peng Liu, Yumei Yan and Wei Bi and has published in prestigious journals such as Circulation, The EMBO Journal and PLoS ONE.

In The Last Decade

Peng Gong

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Gong China 21 467 399 224 216 158 68 1.2k
Laëtitia Delort France 24 627 1.3× 470 1.2× 219 1.0× 300 1.4× 239 1.5× 45 1.6k
Muxing Kang China 19 579 1.2× 328 0.8× 105 0.5× 272 1.3× 154 1.0× 33 1.1k
Yang Fu China 21 506 1.1× 289 0.7× 102 0.5× 141 0.7× 136 0.9× 61 1.1k
Xiaohui Jia China 18 413 0.9× 425 1.1× 104 0.5× 133 0.6× 226 1.4× 53 1.3k
Jing Jiang China 19 577 1.2× 224 0.6× 184 0.8× 251 1.2× 161 1.0× 68 1.5k
Hongsheng Wang China 21 845 1.8× 575 1.4× 120 0.5× 337 1.6× 176 1.1× 49 1.6k
Yan Luo China 15 727 1.6× 552 1.4× 137 0.6× 131 0.6× 78 0.5× 44 1.4k
Xiaotong Hu China 24 1.0k 2.2× 248 0.6× 215 1.0× 416 1.9× 117 0.7× 82 1.7k
Baohong Zhang China 24 579 1.2× 305 0.8× 218 1.0× 74 0.3× 137 0.9× 77 1.6k
Jing Kong China 22 807 1.7× 412 1.0× 163 0.7× 449 2.1× 250 1.6× 67 1.6k

Countries citing papers authored by Peng Gong

Since Specialization
Citations

This map shows the geographic impact of Peng Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Gong more than expected).

Fields of papers citing papers by Peng Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Gong. The network helps show where Peng Gong may publish in the future.

Co-authorship network of co-authors of Peng Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Gong. A scholar is included among the top collaborators of Peng Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Gong. Peng Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, Peng, Yan Hu, Binbin Lu, et al.. (2025). Revealing the biological features of the axolotl pancreas as a new research model. Frontiers in Cell and Developmental Biology. 13. 1531903–1531903.
2.
Chen, Xin, Le Yu, Tao Liu, et al.. (2024). China’s ongoing rural to urban transformation benefits the population but is not evenly spread. Communications Earth & Environment. 5(1). 6 indexed citations
3.
Zhu, Xuefei, Donghui Xia, Yang Liu, et al.. (2024). FOXP1 phosphorylation antagonizes its O-GlcNAcylation in regulating ATR activation in response to replication stress. The EMBO Journal. 44(2). 457–483. 1 indexed citations
4.
Yuan, J., Zeyao Zhu, Ping Zhang, et al.. (2024). SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation. Cancer Letters. 587. 216733–216733. 15 indexed citations
5.
Gong, Peng, et al.. (2023). The functions of FOXP transcription factors and their regulation by post-translational modifications. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1866(4). 194992–194992. 11 indexed citations
6.
Zhang, Wei, Lu Chen, Xianbin Zhang, et al.. (2023). Functionalized nanohybrids with rod shape for improved chemo-phototherapeutic effect against cancer by sequentially generating singlet oxygen and carbon dioxide bubbles. Biomaterials Science. 11(20). 6894–6905. 3 indexed citations
7.
Cheng, Huan, Weihan Liu, Dan Shi, et al.. (2023). Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance. Journal of Experimental & Clinical Cancer Research. 42(1). 199–199. 41 indexed citations
8.
Zhang, Wei, Dan Shi, Milad Ashrafizadeh, et al.. (2023). Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. Drug Resistance Updates. 71. 101005–101005. 38 indexed citations
9.
Zhu, Jing, Junwei Song, Xianbin Zhang, et al.. (2021). SRPK1/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-κB activation in colon cancer. Journal of Translational Medicine. 19(1). 280–280. 31 indexed citations
10.
Shang, Yuru, Xianbin Zhang, Lili Lu, et al.. (2021). Pharmaceutical immunoglobulin G impairs anti-carcinoma activity of oxaliplatin in colon cancer cells. British Journal of Cancer. 124(8). 1411–1420. 10 indexed citations
11.
Li, Lihong, Tengteng Zou, Min Liang, et al.. (2021). Screening of metabolites in the treatment of liver cancer xenografts HepG2/ADR by psoralen-loaded lipid nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 165. 337–344. 10 indexed citations
12.
Cao, Fei, Peng Liu, Xianbin Zhang, et al.. (2019). Shenqi Fuzheng Injection impairs bile duct ligation-induced cholestatic liver injury in vivo. Bioscience Reports. 39(1). 3 indexed citations
13.
Zhang, Bin, Peng Gong, Hong Fu, et al.. (2018). Elemene combined with platinum-containing chemotherapy in elderly patients with recurrent and metastatic breast cancer. 12(2). 73–78. 1 indexed citations
14.
Zhang, Xianbin, Lili Lu, Yuru Shang, et al.. (2017). The number of positive lymph node is a better predictor of survival than the lymph node metastasis status for pancreatic neuroendocrine neoplasms: A retrospective cohort study. International Journal of Surgery. 48. 142–148. 11 indexed citations
15.
Yan, Yumei, Ke Jiang, Peng Liu, et al.. (2016). Bafilomycin A1 induces caspase-independent cell death in hepatocellular carcinoma cells via targeting of autophagy and MAPK pathways. Scientific Reports. 6(1). 37052–37052. 98 indexed citations
16.
Gong, Peng, et al.. (2013). New Insight into Ki67 Expression at the Invasive Front in Breast Cancer. PLoS ONE. 8(1). e54912–e54912. 34 indexed citations
17.
Gong, Peng, et al.. (2012). PPAR expression and its association with SOD and NF-?B in rats with obstructive jaundice. Biomedical Research-tokyo. 23(4). 0. 7 indexed citations
18.
Gong, Peng, et al.. (2002). PCR-based detection of Wolbachia infected in natural populations of wheat aphids in China. 39(3). 188–190. 1 indexed citations
19.
Gong, Peng, et al.. (2001). Microsatellite DNA polymorphism in different forms of the cotton aphid. 44(4). 416–421. 3 indexed citations
20.
Gong, Peng. (2001). Experimental study on myocardial injury and the protective effects of tetramethylpyrazine after biliary obstruction. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026